Are you curious why fast and reliable strain engineering is crucial for the future of biomanufacturing?
Watch the webinar organized by Synonym, in collaboration with EV Biotech, Vectron Biosolutions AS, SynBioBeta,and Enduro Genetics, for an insightful discussion on the critical role of strain engineering in the commercialization of bioproducts.
Synonym and the Boston Consulting Group (BCG)’s recent report reveals that economies of scale alone are not sufficient for commercializing industrial bioproducts. Optimized strains designed for scale are pivotal for unlocking the massive potential of biomanufacturing in the coming decades.
Our expert panel explored the significance of strain optimization and its impact on increasing productivity, enhancing product quality, and achieving cost efficiency in biomanufacturing processes.
Hear from an incredible lineup of industry leaders, and experts:
Crystal Bleecher, PE, VP (Science & Engineering) at Synonym
Christian Munch, CEO at Enduro Genetics
Linda Dijkshoorn, CCO and Founder at EV Biotech
Trond Erik Vee Aune, CEO at Vectron Biosolutions AS
Fiona Mischel (moderator), Director (International) at SynBioBeta
